Electra Therapeutics Inc. (ETRA) vs Neurogene Inc. (NGNE)

Electra Therapeutics Inc. ETRA 9.01 +12.77%
Neurogene Inc. NGNE 25.25 −0.12%

Electra Therapeutics Inc. and Neurogene Inc. are both Biotechnology companies. Electra Therapeutics Inc. and Neurogene Inc. are of similar size ($505.9M and $501.5M).

Metric	ETRA	NGNE	Biotechnology median
P/E	—	n/m	10.96
P/S	—	n/m	9.52
P/B	—	2.64	2.23
Price to free cash flow	—	n/m	25.69
EV/EBITDA	—	n/m	0.68
EV/Sales	—	n/m	9.00
Earnings yield	—	(19.78%)	(32.09%)
Free cash flow yield	—	(15.29%)	(22.62%)

Metric	ETRA	NGNE	Biotechnology median
Gross margin	—	0.00%	68.51%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	(45.32%)	(50.12%)
Return on assets	—	(41.02%)	(45.12%)
Return on invested capital	—	0.00%	0.00%

Metric	ETRA	NGNE	Biotechnology median
Revenue growth (TTM)	—	—	6.78%
EPS growth (last fiscal year)	—	0.93%	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ETRA	NGNE	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	10.64	4.74
Net debt to EBITDA	—	2.57	1.01

Metric	ETRA	NGNE	Biotechnology median
Dividend yield	—	—	0.40%
Payout ratio	—	—	—

Metric	ETRA	NGNE	Biotechnology median
Market cap	501.50m	505.89m	166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack